| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.83B | +7.9% |
| R&D Expense | $24.0M | -57.9% |
| SG&A Expense | $299.0M | +8.7% |
| Interest Expense | $158.0M | +1.3% |
| Pre-tax Income | $1.06B | +268.2% |
| Income Tax | -$55.0M | -120.8% |
| Net Income | $1.16B | +1828.3% |
| EPS (Basic) | $4.40 | +1592.3% |
| EPS (Diluted) | $4.37 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.60B | +40.3% |
| Accounts Receivable | $1.06B | -2.9% |
| Inventory | $2.18B | +9.0% |
| Current Assets | $5.47B | +11.3% |
| Total Assets | $16.13B | +14.7% |
| Current Liabilities | $3.80B | +12.0% |
| Long-term Debt | $2.44B | -4.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.19B | +90.5% |
| Capital Expenditures | $618.0M | +6.6% |
| Investing Cash Flow | -$502.0M | +17.4% |
| Financing Cash Flow | -$261.0M | -229.9% |
| Free Cash Flow | $567.0M | +1250.0% |
| +1580.8% |
| Total Liabilities |
| $9.94B |
| +11.5% |
| Stockholders' Equity | $6.12B | +18.6% |